The FDA also issued a warning to these companies in 2015 for making false claims of effectiveness and medicinal benefits. “Your products are not generally recognized as safe and effective,” the letter read. “Additionally, your product is offered for conditions that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners.”
“Your products are not generally recognized as safe and effective,” is a statement of “general” opinion just like opiates and sedatives are not generally recognized as “safe and effective.” And “Companies are processing large amounts of industrial hemp, which requires the use of harsh chemicals in order to extract enough CBD to be sold on the market” just like cigarettes and tobacco products “use harsh chemicals in order to extract…to be sold on the market.” Therefore, the leading cause of Cancer related deaths is legal to consume and a plant absolutely proven to help the human body combat Cancer is illegal. So, the DEAs’ classification as CBD being illegal…Is most def a GD joke. Don’t be ignorant, do your own research, read states’ compliance outlines and understand that any publication or organization that refers to Cannabis as Marijuana/Marihuana is against it’s legalization.
The half pro/negative of this is that in the majority of these studies, they continued use of CBD — often lowering or raising the dosage — while simultaneously bringing down the dosage of the pharmaceutical. It takes trial and error, but most are successful. Often the end result is a success in lowering the dosage of the pharmaceutical, as well as, seeing an overall improvement of the condition.

If you haven’t been bombarded with CBD marketing or raves about it from friends, get ready. This extract—which comes from either marijuana or its industrial cousin, hemp—is popping up everywhere. There are CBD capsules, tinctures, and liquids for vaping plus CBD-infused lotions, beauty products, snacks, coffee, and even vaginal suppositories. Already some 1,000 brands of CBD products are available in stores—and online in states that don’t have lenient cannabis laws. This is a tiny fraction of what’s to come: The CBD market is poised to exceed $22 billion by 2022, per the Chicago-based research firm Brightfield Group.
While overstimulation of the CB1 receptor may lead to symptoms such as high blood pressure and abnormally high cholesterol levels, CBD is a CB1 antagonist, so it is not likely to cause such issues. Furthermore, the World Health Organization has recently issued a global report on CBD, claiming that it has a good safety profile and minimal adverse public health effects.
If you answered “yes” to step 2. Talk to your doctor as there are several ways you can avoid CBD interacting with your prescription medication. Even high doses of CBD often cause little to no issues due to body chemistry. By monitoring with regular blood tests, even if CBD inhibits too many CYP enzymes, side effects can be prevented by catching the interaction before any harm occurs.
×